Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter A Wohlgemuth

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Scientific Reports|December 20, 2016
The "Intermediate" CD14<sup>++</sup>CD16<sup>+</sup> monocyte subset increases in severe peripheral artery disease in humansMoritz Wildgruber, Teresa Aschenbrenner, Heiko Wendorff, et al.
Atherosclerosis|September 13, 2016
Increased intermediate CD14<sup>++</sup>CD16<sup>++</sup> monocyte subset levels associate with restenosis after peripheral percutaneous transluminal angioplastyMoritz Wildgruber, Maria Czubba, Teresa Aschenbrenner, et al.
Cardiovascular and Interventional Radiology|September 12, 2025
Combining Reversible Electroporation and Bleomycin in Treatment of Arteriovenous MalformationsFlorian Obereisenbuchner, Vanessa F Schmidt, Constantin Goldann, et al.
Radiology and Oncology|June 21, 2023
Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group reportTobian Muir, Giulia Bertino, Ales Groselj, et al.
Plos One|February 7, 2022
Pleuropulmonary pathologies in the early phase of acute pancreatitis correlate with disease severityIna Luiken, Stephan Eisenmann, Jakob Garbe, et al.
Journal of Pediatric Surgery|September 4, 2025
Bleomycin Electrosclerotherapy (BEST) of Slow-Flow Vascular Malformations (SFVMs) in ChildrenJulia Haehl, Beate Haeberle, Oliver Muensterer, et al.
Frontiers in Neurology|April 29, 2026
Bleomycin-Electrosclerotherapy in the treatment of superficial slow-flow vascular malformations of head and neckFlorian Obereisenbuchner, Caroline T Seebauer, Elena Borisch, et al.
United European Gastroenterology Journal|December 17, 2019
Mean muscle attenuation correlates with severe acute pancreatitis unlike visceral adipose tissue and subcutaneous adipose tissueHanna Sternby, Mariella Mahle, Nicolas Linder, et al.
Cardiovascular and Interventional Radiology|June 2, 2022
Image-Guided Embolotherapy of Arteriovenous Malformations of the FaceVanessa F Schmidt, Max Masthoff, Richard Brill, et al.
European Radiology|April 16, 2024
Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and childrenVanessa F Schmidt, Özlem Cangir, Lutz Meyer, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Scientific Reports|December 20, 2016
The "Intermediate" CD14<sup>++</sup>CD16<sup>+</sup> monocyte subset increases in severe peripheral artery disease in humansMoritz Wildgruber, Teresa Aschenbrenner, Heiko Wendorff, et al.
Atherosclerosis|September 13, 2016
Increased intermediate CD14<sup>++</sup>CD16<sup>++</sup> monocyte subset levels associate with restenosis after peripheral percutaneous transluminal angioplastyMoritz Wildgruber, Maria Czubba, Teresa Aschenbrenner, et al.
Cardiovascular and Interventional Radiology|September 12, 2025
Combining Reversible Electroporation and Bleomycin in Treatment of Arteriovenous MalformationsFlorian Obereisenbuchner, Vanessa F Schmidt, Constantin Goldann, et al.
Radiology and Oncology|June 21, 2023
Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group reportTobian Muir, Giulia Bertino, Ales Groselj, et al.
Plos One|February 7, 2022
Pleuropulmonary pathologies in the early phase of acute pancreatitis correlate with disease severityIna Luiken, Stephan Eisenmann, Jakob Garbe, et al.
Journal of Pediatric Surgery|September 4, 2025
Bleomycin Electrosclerotherapy (BEST) of Slow-Flow Vascular Malformations (SFVMs) in ChildrenJulia Haehl, Beate Haeberle, Oliver Muensterer, et al.
Frontiers in Neurology|April 29, 2026
Bleomycin-Electrosclerotherapy in the treatment of superficial slow-flow vascular malformations of head and neckFlorian Obereisenbuchner, Caroline T Seebauer, Elena Borisch, et al.
United European Gastroenterology Journal|December 17, 2019
Mean muscle attenuation correlates with severe acute pancreatitis unlike visceral adipose tissue and subcutaneous adipose tissueHanna Sternby, Mariella Mahle, Nicolas Linder, et al.
Cardiovascular and Interventional Radiology|June 2, 2022
Image-Guided Embolotherapy of Arteriovenous Malformations of the FaceVanessa F Schmidt, Max Masthoff, Richard Brill, et al.
European Radiology|April 16, 2024
Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and childrenVanessa F Schmidt, Özlem Cangir, Lutz Meyer, et al.
Pageof 11